Amplifon S.p.A SG&A Expenses 2019-2024 | AMFPF

Amplifon S.p.A annual/quarterly sg&a expenses history and growth rate from 2019 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Amplifon S.p.A sg&a expenses for the quarter ending September 30, 2024 were $0M, a 0% increase year-over-year.
  • Amplifon S.p.A sg&a expenses for the twelve months ending September 30, 2024 were $0M, a 0% increase year-over-year.
  • Amplifon S.p.A annual sg&a expenses for 2024 were $0B, a 0% decline from 2023.
  • Amplifon S.p.A annual sg&a expenses for 2023 were $0B, a 0% decline from 2022.
  • Amplifon S.p.A annual sg&a expenses for 2022 were $0B, a 0% decline from 2021.
Amplifon S.p.A Annual SG&A Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
Amplifon S.p.A Quarterly SG&A Expenses
(Millions of US $)
2024-09-30
2024-03-31
2023-03-31
2022-03-31
2021-03-31
2020-03-31
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
Sector Industry Market Cap Revenue
Medical Medical Services $5.378B $2.607B
Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.550B 26.36
Elevance Health (ELV) United States $84.617B 10.92
CVS Health (CVS) United States $84.212B 10.47
Cencora (COR) United States $56.918B 19.80
Natera (NTRA) United States $23.467B 0.00
DiDi Global (DIDIY) China $22.356B 23.75
Labcorp Holdings (LH) United States $21.919B 17.78
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.557B 0.00
Solventum (SOLV) United States $12.729B 13.47
CochLear (CHEOY) Australia $12.142B 0.00
ICON (ICLR) Ireland $11.829B 11.00
Revvity (RVTY) United States $11.196B 19.27
Viatris (VTRS) United States $10.411B 3.58
Avantor (AVTR) United States $9.247B 13.44
Medpace Holdings (MEDP) United States $8.892B 23.61
HealthEquity (HQY) United States $8.760B 38.37
Sonic Healthcare (SKHHY) Australia $8.172B 0.00
Charles River Laboratories (CRL) United States $7.242B 14.19
Bausch + Lomb (BLCO) Canada $4.149B 24.44
BrightSpring Health Services (BTSG) United States $3.915B 35.92
Sotera Health (SHC) United States $3.233B 18.37
Alignment Healthcare (ALHC) United States $2.762B 0.00
Concentras Parent (CON) United States $2.658B 15.36
Organon (OGN) United States $2.535B 2.69
Surgery Partners (SGRY) United States $2.473B 32.17
PACS (PACS) United States $2.009B 0.00
GeneDx Holdings (WGS) United States $1.912B 73.63
Ardent Health (ARDT) United States $1.865B 7.95
Premier (PINC) United States $1.816B 13.79
Progyny (PGNY) United States $1.798B 39.58
GoodRx Holdings (GDRX) United States $1.643B 32.86
Teladoc Health (TDOC) United States $1.211B 0.00
Pediatrix Medical (MD) United States $1.136B 8.64
Establishment Labs Holdings (ESTA) $1.093B 0.00
CareDx (CDNA) United States $1.060B 16.56
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.873B 0.00
AMN Healthcare Services Inc (AMN) United States $0.839B 7.85
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
LifeMD (LFMD) United States $0.671B 0.00
Nutex Health (NUTX) United States $0.633B 9.58
Embecta (EMBC) United States $0.571B 3.85
InnovAge Holding (INNV) United States $0.525B 0.00
Enhabit (EHAB) United States $0.469B 38.62
Auna S.A (AUNA) Luxembourg $0.460B 10.35
Sonida Senior Living (SNDA) United States $0.452B 0.00
SBC Medicals (SBC) United States $0.447B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.433B 0.00
Omada Health (OMDA) $0.391B 0.00
Performant Healthcare (PHLT) United States $0.269B 0.00
Oncology Institute (TOI) United States $0.213B 0.00
Beauty Health (SKIN) United States $0.203B 0.00
DocGo (DCGO) United States $0.162B 26.50
Pheton Holdings (PTHL) China $0.128B 0.00
OncoCyte (IMDX) United States $0.121B 0.00
So-Young (SY) China $0.119B 0.00
KindlyMD (NAKA) United States $0.086B 0.00
Sera Prognostics (SERA) United States $0.072B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.053B 0.00
ModivCare (MODV) United States $0.047B 0.00
Basel Medical Group (BMGL) Singapore $0.045B 0.00
Biodesix (BDSX) United States $0.038B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
SeaStar Medical Holding (ICU) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00